DarioHealth Corp.DRIO

$6.93-0.20 (-2.81%)
NASDAQHealthcare24:00 UTC

Company snapshot

Market Cap
$344M
Small-cap
+7%
2016 — today
10-Year Price
-100%
2016 — today
52-Week Range
$6.17$17.35
Current $6.93· 7%

DarioHealth Corp. is a digital therapeutics enterprise operating across the United States, Canada, the European Union, Australia, and New Zealand. The company delivers a suite of digital health solutions, including its 'Dario' metabolic programs designed to address conditions like diabetes, hypertension, and weight management. They also offer 'Dario Musculoskeletal' for preventing and treating common MSK conditions, and 'Dario' behavioral health solutions to improve access to evidence-based care. Their offerings extend to general chronic condition management solutions and DarioEngage, a proprietary care management platform. In terms of hardware, DarioHealth provides smart glucose meters, Bluetooth-connected blood pressure cuffs, digital scales, biofeedback sensor devices, and disposables such as test strip cartridges and lancets for blood glucose monitoring systems. Furthermore, they offer comprehensive diabetes management programs that integrate lifestyle changes, healthy eating guidance, advanced tracking tools, and live coaching. Founded in 2011, the company was formerly known as LabStyle Innovations Corp. before officially changing its name to DarioHealth Corp. in July 2016. Its headquarters are located in New York, New York.

Valuation in context

P/E ratio
3.1
Historically pricey
Historically pricey — last 10 years
P/B ratio
5.5
Near historic low
Near historic low — last 10 years
FCF Yield
-7.4%
Near historic low
Near historic low — last 10 years
Free · No credit card needed

Get alerted when DRIO is cheap

Set a free alert — we'll push you when P/E, yield, or other metrics cross a historical threshold.